Publications related to the WECARE study test
Listed by Year

• 2012
  • Tischkowitz M, Capanu M, Sabbaghian N, Li L, Liang X, Vallee M, Tavtigian S, Concannon P, Foulkes WD, Bernstein L, Bernstein JL, Begg CB. Rare Germline Mutations in PALB2 and Breast Cancer Risk: A Population-Based Study. Hum Mutat.2012
• 2011
  • Teraoka SN, Bernstein JL, Reiner AS, Haile RW, Bernstein L, Lynch CF, Malone KE, Stovall M, Capanu M, Liang X, Smith SA, Mychaleckyj J, Hou X, Mellemkjaer L, Boice JD Jr, Siniard A, Duggan D, Thomas DC, the WECARE Study Collaborative Group and Concannon P. Single nucleotide polymorphisms associated with risk for contralateral breast cancer in the Women's Environment, Cancer and Radiation Epidemiology (WECARE) study. Breast Cancer Res. 2011 Nov 17;13(6):R114. [Epub ahead of print]
  • Brooks JD, Teraoka S, Reiner AS, Satagopan J, Bernstein L, Thomas DC, Capanu M, Stovall M, Smith SA, Wei S, Shore RE, Boice, Jr. JD, Lynch CF, Mellemkjær L, Malone KE, Liang X, the WECARE Study Collaborative Group, Haile RW, Concannon P, Bernstein JL. Variants in Activators and Downstream Targets of ATM, Radiation Exposure, and Contralateral Breast Cancer Risk in the WECARE Study. Hum Mutat.2011.[Epub ahead of print].
  • Brooks JD, John EM, Mellemkjær L, Reiner AS, Malone KE, Lynch CF, Figueiredo JC, Haile RW, Shore RE, The WECARE Study Collaborative Group, Bernstein JL, Bernstein L. Body mass index and risk of second primary breast cancer: The WECARE Study. Breast Cancer Res Treat.2011. [Epub ahead of print]
  • Brooks JD, Boice JD, Jr, Stovall M, Reiner AS, Bernstein L, John EM, Lynch CF, Mellemkjær L, Knight JA, Thomas DC, Haile RW, Smith SA, Capanu C, The WECARE Collaborative Group, Bernstein JL, Shore RE. Reproductive status at first diagnosis influences risk of radiation-induced second primary contralateral breast cancer in The WECARE Study. Int J Radiat Oncol Biol Phys. [Under review]
  • Capanu M, Concannon P, Haile RW, Bernstein L, Malone KE, Lynch CF, Liang X, Teraoka SN, Diep AT, Thomas DC, Bernstein JL, The WECARE Study Collaborative Group, Begg CB. Assessment of rare BRCA1 and BRCA2 variants of unknown significance using hierarchical modeling. Genet Epidemiol.2011;Jul;35(5):389-97.
  • Figueiredo JC, Brooks JD, Conti DV, Poynter JN, Teraoka SN, Malone KE, Bernstein L, Lee WD, Duggan DJ, Siniard A, Concannon P, Capanu M, Lynch CF, Olsen JH, Haile RW, Bernstein JL. Risk of contralateral breast cancer associated with common variants in BRCA1 and BRCA2: potential modifying effect of BRCA1/BRCA2 mutation carrier status. Breast Cancer Res Treat.2011;Jun;127(3):819-29.
  • Quintana MA, Bernstein JL, Thomas DC, Conti DV. Incorporating Model Uncertainty in Detecting Rare Variants: The Bayesian Risk Index.Genet Epidemiol.2011;Nov;35(7):638-49.
  • Submitted Original Peer-Reviewed Articles
    • Bernstein JL, Thomas DC, Shore RE, Robson M, Boice JD, Stovall M, Andersson M, Bernstein L, Malone KE, Reiner AS, Lynch CF, Capanu M, Smith SA, Tellhed L, Xue S, Teraoka SN, Begg CB, Olsen JH, Mellemkjaer L, Liang X, Olson E, Diep AT, The WECARE Study Collaborative Group, Borg A, Concannon P, Haile RW. Radiation-induced second primary breast cancer and BRCA1 and BRCA2 mutation carrier status: A report from the WECARE Study. [Submitted]
    • Teraoka SN, Bernstein JL, Reiner AS, Haile RW, Bernstein L, Lynch CF, Malone KE, Stovall M, Capanu M, Liang X, Smith SA, Mychaleckyj J, Hou X, Mellemkjaer L, Boice Jr. JD, Siniard A, Duggan D, Thomas DC, The WECARE Study Collaborative Group, and Concannon P. Single nucleotide polymorphisms associated with risk for contralateral breast cancer in the Women’s Environment, Cancer and Radiation Epidemiology (WECARE) study. [Submitted]
• 2010
  • Borg A, Haile RW, Malone KE, Capanu M, Diep A, Törngren T, Teraoka S, Begg CB, Thomas DC, Concannon P, Mellemkjaer L, Bernstein L, Tellhed L, Xue S, Olson ER, Liang X, Dolle J, Børresen-Dale AL, Bernstein JL. Characterization of BRCA1 and BRCA2 deleterious mutations and variants of unknown clinical significance in unilateral and bilateral breast cancer: the WECARE study. Hum Mutat 2010; 31(3):E1200-1240.
  • Bernstein JL, Haile RW, Stovall M, Boice J, Shore R, Langholz B, Thomas D, Bernstein L, Lynch C, Olsen J, Malone K, Mellemkjaer L, Borrensen-Dale A, Rosenstein B, Teraoka S, Diep A, Smith S, Capanu M, Reiner A, Liang X, Gatti RA, The WECARE Study Collaborative Group, Concannon P. Radiation exposure, the ATM gene, and contralateral breast cancer in the WECARE Study. J Natl Cancer Inst. 2010;102(7):475-483.
  • Figueiredo JC, Haile RW, Bernstein L, Malone KE, Largent J, Langholz B, Lynch CF, Bertelsen L, Capanu M, Concannon P, Borg A, Børresen-Dale AL, Diep A, Teraoka S, Torngren T, Xue S, Bernstein JL. Oral contraceptives and postmenopausal hormones and risk of contralateral breast cancer among BRCA1 and BRCA2 mutation carriers and noncarriers: the WECARE Study. Breast Cancer Res Treat 2010; 120(1):175-183.
  • Kathleen E. Malone, Colin B. Begg, Robert W. Haile, Ake Borg, Patrick Concannon, Lina Tellhed, Shanyan Xue, Sharon Teraoka, Leslie Bernstein, Marinela Capanu, Anne S. Reiner, Elyn R. Riedel, Duncan C. Thomas, Lene Mellemkjær, Charles F. Lynch, John D. Boice Jr, Hoda Anton-Culver, and Jonine L. Bernstein. A population-based study of the relative and absolute risks of contralateral breast cancer associated with carrying a mutation in BRCA1 or BRCA2: results from the WECARE Study. J Clin Oncol 28(14):2404-10.
  • Poynter JN, Langholz B, Largent J, Mellemkjær L, Bernstein L, Malone KE, Lynch CF, Borg A, Concannon P, Teraoka SN, Xue S, Diep AT, Törngren T, Begg CB, Capanu M, Haile RW; The WECARE Study Collaborative Group, Bernstein JL. Reproductive factors and risk of contralateral breast cancer by BRCA1 and BRCA2 mutation status: results from the WECARE Study. Cancer Causes Control. 2010;21(6):839-846.
  • Reding KW, Bernstein JL, Langholz BM, Bernstein L, Haile RW, Begg CB, Lynch CF, Concannon P, Borg A, Teraoka SN, Törngren T, Diep A, Xue S, Bertelsen L, Liang X, Reiner AS, Capanu M, Malone KE; WECARE Collaborative Study Group. Adjuvant systemic therapy for breast cancer in BRCA1/BRCA2 mutation carriers in a population-based study of risk of contralateral breast cancer. Breast Cancer Res Treat.2010;123(2):491-498.
• 2009
  • Figueiredo JC, Haile RW, Bernstein JL. Oral Contraceptives and Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers. Current Breast Cancer Reports. June 2009
  • Knight JA, Bernstein L, Largent J, Capanu M, Begg CB, Mellemkjaer L, Lynch CF, Malone KE, Reiner AS, Liang X, Haile RW, Boice JD Jr; WECARE Study Collaborative Group, Bernstein JL. Alcohol intake and cigarette smoking and risk of a contralateral breast cancer: The Women's Environmental Cancer and Radiation Epidemiology Study. Am J Epidemiol. 2009 Apr 15;169(8):962-8. Epub 2009 Feb 11.
• 2008
  • Begg CB, Haile RW, Borg A, Malone KE, Concannon P, Thomas DC, Langholz B, Bernstein L, Olsen JH, Lynch CF, Anton-Culver H, Capanu M, Liang X, Hummer AJ, Sima C, Bernstein JL.Variation of Breast Cancer Risk Among BRCA1/2 Carriers. JAMA 299(2):194-201, 2008.
  • Bertelsen L, Bernstein L, Olsen JH, Mellemkjaer L, Haile R, Lynch CF, Malone KE, Anton-Culver H, Christensen J, Langholz B, Thomas DC, Begg C, Capanu M, Ejlertsen B, Stovall M, Boice Jr JD, Shore RE, Bernstein JL, The WECARE Study Collaborative Group. Effect of systemic adjuvant treatment on risk for contralateral breast cancer in the Women's Environment, Cancer and Radiation Epidemiology study. JNCI 100(1):32-40, 2008.
  • Concannon P, Haile RW, Børresen-Dale AL, Rosenstein BS, Gatti RA, Teraoka SN, Diep TA, Jansen L, Atencio DP, Langholz B, Capanu M, Liang X, Begg CB, Thomas DC, Bernstein L, Olsen JH, Malone KE, Lynch CF, Anton-Culver H, Bernstein JL; Women's Environment, Cancer, and Radiation Epidemiology Study Collaborative Group.Variants in the ATM gene associated with a reduced risk of contralateral breast cancer. Cancer Res. 2008 Aug 15;68(16):6486-91.
  • Figueiredo JC, Bernstein L, Capanu M, Malone KE, Lynch CF, Anton-Culver H, Stovall M, Børresen-Dale A, Haile RW, Bernstein JL, The WECARE Study Collaborative Group. Oral Contraceptives, Postmenopausal Hormones, and Risk of Asynchronous Bilateral Breast Cancer: The WECARE Study Group. J Clin Oncol 2008 Mar 20;26(9):1411-8.
  • Langholz B, Thomas DC, Stovall M, Smith SA, Boice JD Jr, Shore RE, Bernstein L, Lynch CF, Zhang X, Bernstein JL.Statistical Methods for Analysis of Radiation Effects with Tumor and Dose Location-Specific Information with Application to the WECARE Study of Asynchronous Contralateral Breast Cancer. Biometrics. 2008 Jul 21.
  • Mellemkjær1 L, Dahl C, Olsen JH, Bertelsen L, Guldberg P, Christensen J, Børresen-Dale A-L, Stovall M, Langholz B, Bernstein L, Lynch CF, Malone KE, Haile RW, Andersson M, Thomas DC, Concannon P, Capanu M, Boice JD jr, The WECARE Study Collaborative Group, Bernstein JL. Risk for contralateral breast cancer among carriers of the CHEK2(*)1100delC mutation in the WECARE Study. Br J Ca. 2008 Feb 26;98(4):728-33.
  • Stovall M, Smith SA, Langholz BM, Boice JD, Shore RE, Andersson M, Bucholz TA, Capanu M, Bernstein L, Lynch CF, Malone KE, Anton-Culver H, Haile RW, Reiner AS, Thomas DC, Bernstein JL. Dose to the contralateral breast from radiation theapy and risk of second primary breast cancer in the WECARE Study. Int J Radiat Oncol Biol Phys. 2008 Nov 15;72(4):1021-30. Epub 2008 Jun 14.
• 2007
  • Langholz B, Thomas DC, Stovall M, Smith S, Boice JD, Shore RE, Bernstein JL. Analysis of radiation dose-response with tumor location and location-specific dose in the WECARE Study of second breast cancer. Radiation Research 2007; 167:358-359.
  • Largent JA, Capanu M, Bernstein L, Langholz B, Mellemkjaer L, Malone KE, Begg C, Haile RW, Lynch CF, Anton-Culver H, Wolitzer A, Bernstein JL. Reproductive history and risk of second primary breast cancer: the WECARE study. Cancer Epidemiol Biomarkers Prev 16(5): 906-911, 2007.
• 2006
  • Langholz B, Bernstein JL, Bernstein L, Olsen JH, Borresen-Dale AL, Rosenstein BS, Gatti RA, Concannon P. On the proposed association of the ATM variants 5557G>A and IVS38-8T>C and bilateral breast cancer. Int J Cancer Aug 1; 119(3): 724-5, 2006. (letter)
• 2005
  • Bernstein JL, Concannon P, Langholz B, Thompson WD, Bernstein L, Stovall M, Thomas DC; WECARE Study Collaborative Group. Multi-center screening of mutations in the ATM gene among women with breast cancer - the WECARE Study. Radiat Res. 163(6):698-9, 2005. (abstract- but it comes up in pub med)
• 2004
  • Bernstein JL, Langholz BM, Haile RW, Bernstein L, Thomas DC, Stovall M, Malone KE, Lynch CF, Olsen JH, Anton-Culver H, Shore RE, Boice Jr. JD, Berkowitz GS, Gatti RA, Teitelbaum SL, Smith SA, Rosenstein BS, Borresen-Dale A, Concannon P, Thompson WD. Study Design: Evaluating gene-environment interactions in the etiology of breast cancer - the WECARE study. Br Ca Res 6(3):R199-R214, 2004.
• 2003
  • Bernstein JL, Bernstein L, Thompson WD, Lynch CF, Malone K, Teitelbaum SL, Olsen JH, Anton-Culver H, Boice JD Jr., Rosenstein BS, Børresen-Dale A, Gatti RA, Concannon P, Haile RW, and the WECARE Study Collaborative Group. ATM variants 7271T>G and IVS10-6T>G among women with unilateral and bilateral breast cancer. Br J Cancer 89(8): 1513-1516, 2003.
  • Bernstein JL, Teraoka S, Haile RW, Børresen-Dale AL, Rosenstein BS, Gatti RA, Diep AT, Jansen L, Atencio DP, Olsen JH, Bernstein L, Teitelbaum SL, Thompson WD, Concannon P; WECARE Study Collaborative Group. Designing and Implementing Quality Control for Multi-Center Screening of Mutations in the ATM Gene Among Women with Breast Cancer. Hum Mutat. 21(5):542-50, 2003
• 2002
  • Bernstein JL, Seminara D, Børresen-Dale AL. Workshop on The Epidemiology of the ATM Gene: Impact on Breast Cancer Risk and Treatment, Present Status and Future Focus, Lillehammer, Norway, 29 June 2002. Workshop on Epidemiology of the ATM Gene: Impact on Breast Cancer Risk and Treatment, Present Status and Future Focus. Breast Cancer Res. 4(6):249-52, 2002.